title: Hematometra complicating hormone replacement therapy after radiation for cervical carcinoma.
abstract: Hematometra developed in a patient receiving sequential estrogen-progestogen hormone replacement therapy following radiation for cervical carcinoma. Diagnosis, treatment and therapeutic recommendations are discussed.
authors.affiliation: Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.
authors.forename: M V
authors.initials: MV
authors.lastname: Sauer
authors.forename: M
authors.initials: M
authors.lastname: Tomlinson
authors.forename: W
authors.initials: W
authors.lastname: Rich
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy*; D004359:Drug Therapy, Combination; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects*; D005260:Female; D006409:Hematometra / Q000139:chemically induced*; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects*; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*
chemical_list: D004966:Estrogens, Conjugated (USP); D008525:Medroxyprogesterone